This finding is in agreement with what was observed by previous studies, as the results showed a low count of CD3+, CD4+, and CD8+ T cells in COVID-19 patients, particularly in moderate and severe cases (20, 34, 35). The gene discussed is CD4; the disease is COVID-19.